HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard van Hillegersberg Selected Research

Stents

11/2014Biodegradable stent placement before neoadjuvant chemoradiotherapy as a bridge to surgery in patients with locally advanced esophageal cancer.
4/2013Early severe mediastinal bleeding after esophagectomy: a potentially lethal complication.
2/2012Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009: a survey in the Netherlands.
12/2010A patient with tracheoesophageal fistula and esophageal cancer after radiotherapy.
9/2006Aortoesophageal fistula successfully treated by endovascular stent-graft.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard van Hillegersberg Research Topics

Disease

92Neoplasms (Cancer)
08/2022 - 11/2005
70Esophageal Neoplasms (Esophageal Cancer)
12/2022 - 07/2008
26Adenocarcinoma
02/2022 - 01/2003
25Neoplasm Metastasis (Metastasis)
06/2022 - 11/2005
18Stomach Neoplasms (Stomach Cancer)
01/2022 - 03/2012
16Anastomotic Leak
07/2022 - 08/2012
9Lymphatic Metastasis
02/2022 - 01/2016
7Breast Neoplasms (Breast Cancer)
12/2015 - 12/2007
6Pneumonia (Pneumonitis)
01/2022 - 01/2014
6Carcinoma (Carcinomatosis)
11/2021 - 01/2003
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2021 - 05/2008
4Gastrointestinal Neoplasms (Gastrointestinal Cancer)
11/2021 - 11/2017
4Weight Loss (Weight Reduction)
11/2020 - 01/2015
4Pathologic Complete Response
04/2020 - 05/2015
4Deglutition Disorders (Dysphagia)
01/2018 - 12/2010
3Margins of Excision
01/2022 - 06/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
11/2019 - 02/2014
3Malnutrition (Nutritional Deficiencies)
10/2017 - 07/2017
3Hiatal Hernia
04/2017 - 01/2005
3Thrombosis (Thrombus)
04/2015 - 04/2002
3Pathologic Constriction (Stenosis)
07/2013 - 12/2010
2Recurrent Laryngeal Nerve Injuries
11/2022 - 07/2017
2Wounds and Injuries (Trauma)
01/2022 - 10/2018
2Lymphopenia (Lymphocytopenia)
11/2021 - 10/2021
2Liver Diseases (Liver Disease)
01/2021 - 09/2014
2Esophageal Squamous Cell Carcinoma
06/2019 - 05/2008
2Chylothorax
01/2019 - 05/2018
2Infections
08/2017 - 06/2012
2Fistula
07/2017 - 09/2006
2Disease Progression
06/2017 - 04/2017
2Neoplasm Micrometastasis
02/2017 - 01/2009
2Hernia (Hernias)
11/2016 - 06/2016
2Residual Neoplasm
01/2016 - 06/2015
2Hemorrhage
07/2013 - 04/2013
2Carcinoid Tumor (Carcinoid)
06/2006 - 11/2005
2Necrosis
05/2006 - 01/2006
2Hyperplasia
01/2003 - 09/2002
1Paralysis (Palsy)
02/2022
1Connective Tissue Diseases (Connective Tissue Disease)
01/2021
1Myocardial Infarction
01/2021
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2021
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2020
1Atrial Fibrillation
04/2019
1Postoperative Pain
04/2019
1Pancreatic Fistula (Pancreatic Fistulas)
01/2019
1Scoliosis
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2018

Drug/Important Bio-Agent (IBA)

6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2022 - 01/2018
3Biomarkers (Surrogate Marker)IBA
02/2022 - 05/2008
3Paclitaxel (Taxol)FDA LinkGeneric
09/2018 - 06/2017
3Carboplatin (JM8)FDA LinkGeneric
09/2018 - 06/2017
2Dihydrotachysterol (AT 10)IBA
07/2022 - 11/2020
2Capecitabine (Xeloda)FDA Link
09/2018 - 06/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 02/2017
2ParaffinIBA
02/2012 - 05/2008
2Formaldehyde (Formol)FDA Link
02/2012 - 05/2008
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022
1PlasticsIBA
12/2021
1atezolizumabIBA
01/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2020
1Triglycerides (Triacylglycerol)IBA
01/2019
1Docetaxel (Taxotere)FDA Link
09/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2018
1Estrogen ReceptorsIBA
07/2018
1dihydrouracilIBA
06/2018
1UracilIBA
06/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1cyclo(Arg-Pro) (CI 4)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018

Therapy/Procedure

78Esophagectomy
12/2022 - 09/2006
45Neoadjuvant Therapy
06/2022 - 07/2008
26Therapeutics
08/2022 - 09/2002
25Lymph Node Excision (Lymph Node Dissection)
11/2022 - 05/2008
23Gastrectomy
01/2022 - 05/2013
14Chemoradiotherapy
08/2022 - 09/2014
13Radiotherapy
08/2022 - 06/2006
12Drug Therapy (Chemotherapy)
08/2022 - 02/2012
12Radiofrequency Ablation
11/2019 - 11/2005
7Length of Stay
01/2022 - 04/2014
5Aftercare (After-Treatment)
11/2018 - 01/2003
5Stents
11/2014 - 09/2006
4Minimally Invasive Surgical Procedures
11/2021 - 04/2019
4Enteral Nutrition (Feeding, Tube)
01/2019 - 01/2015
3Operative Surgical Procedures
07/2021 - 05/2012
3Hepatectomy
07/2018 - 05/2010
3Jejunostomy
08/2017 - 06/2012
2Metastasectomy
08/2022 - 01/2022
2Adjuvant Chemoradiotherapy
09/2018 - 08/2018
2Adjuvant Chemotherapy
09/2018 - 03/2015
2Enhanced Recovery After Surgery
07/2017 - 09/2014
2Fundoplication
06/2016 - 09/2014
2Brachytherapy
02/2012 - 12/2010
2Cryosurgery
07/2010 - 05/2010
2Lasers (Laser)
05/2010 - 02/2006
2Induced Hyperthermia (Thermotherapy)
05/2010 - 02/2006
2Electrodes (Electrode)
05/2006 - 01/2006
1Time-to-Treatment
01/2022
1Postoperative Care
12/2018
1Self Expandable Metallic Stents
01/2018
1Pedicle Screws
01/2018